Cytokine & Growth Factor Reviews

Papers
(The H4-Index of Cytokine & Growth Factor Reviews is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system999
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease813
Cytokine storm intervention in the early stages of COVID-19 pneumonia358
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons299
IL-6: Relevance for immunopathology of SARS-CoV-2223
The global impact of the coronavirus pandemic210
Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes131
SARS-CoV-2 Mutations and their Viral Variants107
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies90
The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved85
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders80
The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-1978
Hallmarks of aging and immunosenescence: Connecting the dots72
Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients70
Mechanisms of NLRP3 priming in inflammaging and age related diseases68
The Covid-19 pandemic in Denmark: Big lessons from a small country64
A critical evaluation of glucocorticoids in the management of severe COVID-1964
Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?60
Crosstalk between glucose metabolism, lactate production and immune response modulation58
Applications of the regenerative capacity of platelets in modern medicine54
Semaphorins in health and disease48
Receptor binding competition: A paradigm for regulating TGF-β family action47
Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy46
ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression45
Chemokine networks modulating natural killer cell trafficking to solid tumors44
SARS-CoV-2: Targeted managements and vaccine development44
Growth differentiation factor-15 and its role in diabetes and cardiovascular disease43
Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia40
Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?40
SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities40
S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes39
Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy39
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?38
Engineering and combining oncolytic measles virus for cancer therapy37
FGF/FGFR signaling: From lung development to respiratory diseases37
Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease36
Scarless wound healing: Current insights from the perspectives of TGF-β, KGF-1, and KGF-236
Biological functions and therapeutic opportunities of soluble cytokine receptors36
A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization36
0.028037071228027